FRED HUTCHINSON CANCER CENTER
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
- Conditions
- Adult Acute Myeloid Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Myelodysplastic SyndromeChildhood Renal Cell CarcinomaChronic Myelomonocytic LeukemiaClear Cell Renal Cell Carcinomade Novo Myelodysplastic SyndromeMetastatic Renal Cell CancerPreviously Treated Myelodysplastic Syndrome
- Interventions
- Radiation: Total-Body IrradiationProcedure: Peripheral Blood Stem Cell TransplantationProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-12-20
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 106
- Registration Number
- NCT00027820
- Locations
- 🇺🇸
Stanford University Hospitals and Clinics, Stanford, California, United States
🇺🇸University of Arizona Health Sciences Center, Tucson, Arizona, United States
🇺🇸Emory University/Winship Cancer Institute, Atlanta, Georgia, United States
Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone
- Conditions
- Metastatic CancerSarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-12-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00006234
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00006233
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
- Conditions
- Leukemia
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00027547
- Locations
- 🇺🇸
Cancer Institute at Oregon Health and Science University, Portland, Oregon, United States
🇩🇪Universitaet Leipzig, Leipzig, Germany
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
- Conditions
- Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00045292
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸UNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
- Conditions
- Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00049465
- Locations
- 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇺🇸Stanford University Medical Center, Stanford, California, United States
🇺🇸Shands Hospital and Clinics, University of Florida, Gainesville, Florida, United States
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
- Conditions
- Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-16
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00049634
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸Seattle Cancer Care Alliance, Seattle, Washington, United States
Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00012207
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸University of Washington School of Medicine, Seattle, Washington, United States
Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma
- Conditions
- Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
- Interventions
- Biological: recombinant interferon alfaBiological: aldesleukinProcedure: in vitro-treated peripheral blood stem cell transplantation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT00006244
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation
- Conditions
- Long-term Effects Secondary to Cancer Therapy in ChildrenPulmonary Complications
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 280
- Registration Number
- NCT00009711
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States